Acceptance and Commitment Therapy for Chronic Pain in Cancer Survivors

University of Colorado Denver (CU Denver)

Status: Completed

Conditions: Chronic Pain

Treatments: Other: Treatment as Usual; Behavioral: Acceptance and Commitment Therapy

Study type: Interventional

Funder types: Other

Identifiers

NCT03661840

18-1102.cc

Details and patient eligibility

About

A study to help manage chronic pain in cancer survivors through Acceptance and Commitment Therapy (ACT) after undergoing active cancer treatment, such as surgery, chemotherapy, and/or radiation.

Full description

This study attempts to apply effective pain management interventions from other chronic pain populations to those of cancer related populations. It will assess the ability of ACT to alleviate chronic cancer related pain and evaluate ease of implementation of treatment. Patients will be allocated to either the intervention group (ACT) or the control group, getting them the usual course of treatment.

Enrollment: 50 patients

Sex: All

Ages: 18 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Provision to sign and date the consent form
2. Stated willingness to comply with all study procedures and be available for the duration of the study
3. Be a male or female aged 18-100
4. Have pathology confirmed diagnosis of a solid tumor cancer
5. Be three or more months out from active cancer treatment (surgery, chemotherapy, and/or radiation)
6. Endorses experiencing pain for three or more months prior to eligibility screening
7. Indicates moderate to severe difficulties with pain interference as related to their cancer experience, with a score of 4 or higher on the pain interference item from the Chronic Pain Grading Questionnaire
8. Shows no evidence of cancer disease (NED) or with stable, chronic disease under "watchful waiting"
9. Fluent in English
10. Psychiatric stability as assessed by chart review and study personnel (e.g., not exhibiting symptoms consistent with diagnoses of serious mental illness such as active psychosis or mania)

Exclusion criteria

1. Having pain that can be solely attributed to a diagnosis outside of their cancer experience
2. Presenting with barriers to group participation (e.g., social anxiety) or when group-based provision of care would impede participant's treatment or that of other group members
3. Patients with a diagnosis of malignant neoplasm of the brain (ICD-10 C71) or malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system (ICD-10 C72).

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

50 participants in 2 patient groups

Acceptance and Commitment Therapy

Experimental group

Description:

Participants will receive both the ACT intervention and medication management that is given as usual treatment.

Treatment:

Behavioral: Acceptance and Commitment Therapy

Treatment as Usual

Active Comparator group

Description:

Treatment as usual will include ongoing provision of usual treatment options for pain management.

Treatment:

Other: Treatment as Usual